FDA
approval
· 2024-06-05
FDA Approved: SUMATRIPTAN — Supplemental Application (Cipla USA Inc.)
Summary
The FDA approved a supplemental application for Sumatriptan from Cipla USA Inc., supporting marketing of this generic migraine medication. The action pertains t…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for SUMATRIPTAN (SUMATRIPTAN)